Some pathogens, including parasites of the genus Trypanosoma causing Human and Animal African Trypanosomiases, cannot synthesize purines de novo and they entirely rely on the purine salvage pathway (PSP) for their nucleotide generation. Thus, their PSP enzymes are considered as promising drug targets, sparsely explored so far. Recently, a significant role of acyclic nucleoside phosphonates (ANPs) as inhibitors of key enzymes of PSP, namely of 6-oxopurine phosphoribosyltransferases (PRTs), has been discovered. Herein, we designed and synthesized two series of new ANPs branched at the C1' position as mimics of adenosine monophosphate. The novel ANPs efficaciously inhibited Trypanosoma brucei adenine PRT (TbrAPRT1) activity in vitro and it was shown that the configuration on the C1' chiral centre strongly influenced their activity: the (R)-enantiomers proved to be more potent compared to the (S)-enantiomers. Two ANPs, with Ki values of 0.39 μM and 0.57 μM, represent the most potent TbrAPRT1 inhibitors reported to date and they are an important tool to further study purine metabolism in various parasites.

Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences Flemingovo nám 2 160 00 Prague 6 Czech Republic

Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences Flemingovo nám 2 160 00 Prague 6 Czech Republic; Department of Organic Chemistry Faculty of Science Charles University Hlavova 8 128 43 Prague 2 Czech Republic

Institute of Parasitology Biology Centre Czech Academy of Sciences Branišovská 31 České Budějovice 37005 Czech Republic

Institute of Parasitology Biology Centre Czech Academy of Sciences Branišovská 31 České Budějovice 37005 Czech Republic; Faculty of Science University of South Bohemia Branišovská 31 České Budějovice 37005 Czech Republic

Citace poskytuje Crossref.org

Phosphonates and Phosphonate Prodrugs in Medicinal Chemistry: Past Successes and Future Prospects